Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors

scientific article

Contrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors is …
instance of (P31):
meta-analysisQ815382
scholarly articleQ13442814

External links are
P819ADS bibcode2015PLoSO..1018872Q
P356DOI10.1371/JOURNAL.PONE.0118872
P932PMC publication ID4357383
P698PubMed publication ID25764442
P5875ResearchGate publication ID273912805

P2093author name stringJing Yu
Man Li
Na Li
Chen Song
Zhe Yu
Jing-Jing Qiao
P2860cites workMeta-analysis of genetic association studies supports a contribution of common variants to susceptibility to common diseaseQ22337234
Comparison of two methods to detect publication bias in meta-analysisQ29617904
Evaluation of QUADAS, a tool for the quality assessment of diagnostic accuracy studies.Q33235606
Multivariate random effects meta-analysis of diagnostic tests with multiple thresholdsQ33515692
Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control studyQ34613673
New perspectives for the use of contrast-enhanced liver ultrasound in clinical practice.Q36701684
Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancerQ37023236
Impact of screening test performance and cost on mortality reduction and cost-effectiveness of multimodal ovarian cancer screeningQ37059558
New potential and applications of contrast-enhanced ultrasound of the breast: Own investigations and review of the literatureQ37314564
Angiogenesis, vasculogenesis, and vasculogenic mimicry in ovarian cancerQ37513086
Contrast-enhanced ultrasound: what is the evidence and what are the obstacles?Q37525915
Novel contrast-enhanced ultrasound imaging in prostate cancerQ38656611
Contrast imaging ultrasound detects abnormalities in the marmoset ovaryQ39569667
Can contrast-enhanced sonography distinguish benign from malignant breast masses?Q39919022
Targeting an ultrasound contrast agent to folate receptors on ovarian cancer cells: feasibility research for ultrasonic molecular imaging of tumor cellsQ43106736
Diagnostic parameters to differentiate benign from malignant ovarian masses with contrast-enhanced transvaginal sonographyQ43271805
Prognostic value of pre-treatment DCE-MRI parameters in predicting disease free and overall survival for breast cancer patients undergoing neoadjuvant chemotherapyQ44599093
Contrast-enhanced transvaginal sonography of benign versus malignant ovarian masses: preliminary findingsQ46520511
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS).Q51129805
Assessment of tissue perfusion by contrast-enhanced ultrasoundQ51650477
Disseminated tumor cells in bone marrow may affect prognosis of patients with gynecologic malignancies.Q51821584
[Value of color Doppler ultrasonography, contrast-enhanced ultrasound and serum CA-125 detection in differential diagnosis of ovarian masses].Q53327247
Independent prognostic relevance of microvessel density in advanced epithelial ovarian cancer and associations between CD31, CD105, p53 status, and angiogenic marker expression: A Gynecologic Oncology Group study.Q53424963
Contrast-enhanced ultrasonography of peripheral soft-tissue tumors: Feasibility study and preliminary results.Q53677186
Contrast-enhanced ultrasound vs multidetector-computed tomography for detecting liver metastases in colorectal cancer: a prospective, blinded, patient-by-patient analysisQ57778635
Ovarian CancerQ63966715
HEGESMA: genome search meta-analysis and heterogeneity testingQ81849916
Ultrasound microbubble contrast and current clinical applicationsQ83166866
Impact of combination chemotherapy with itraconazole on survival of patients with refractory ovarian cancerQ95352432
[Diagnostic value of contrast-enhanced ultrasonography in ovarian tumors]Q95393094
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue3
P407language of work or nameEnglishQ1860
P304page(s)e0118872
P577publication date2015-03-12
P1433published inPLOS OneQ564954
P1476titleContrast-enhanced ultrasonography in differential diagnosis of benign and malignant ovarian tumors
P478volume10

Reverse relations

cites work (P2860)
Q90339244A preliminary study: The sequential use of the risk malignancy index and contrast-enhanced ultrasonography in differential diagnosis of adnexal masses
Q64104351Ability of F-FDG PET/CT Radiomic Features to Distinguish Breast Carcinoma from Breast Lymphoma
Q89736413Application Value of Color Doppler Ultrasound and Ultrasound Contrast in the Differential Diagnosis of Ovarian tumor
Q41223900Clinical value of combining transvaginal contrast-enhanced ultrasonography with serum human epididymisprotein-4 and the resistance index for early-stage epithelial ovarian cancer
Q55452489Combination of serum CA19-9 and CA125 levels and contrast-enhanced ultrasound parametric data facilitates to differentiate ovarian serous carcinoma from ovarian malignant epithelial cancer.
Q41337070Diagnostic accuracy of contrast-enhanced ultrasound for characterization of kidney lesions in patients with and without chronic kidney disease